Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

0.99
Delayed Data
As of Jul 29
 +0.0199 / +2.05%
Today’s Change
0.64
Today|||52-Week Range
4.83
-31.72%
Year-to-Date
No recent news for MannKind Corp.

Today’s Trading

Previous close0.97
Today’s open0.97
Day’s range0.95 - 1.00
Volume2,002,289
Average volume (3 months)4,869,252
Market cap$477.7M
Dividend yield--
Data as of 3:59pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+74.18%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SPPISpectrum Pharmaceuti...+0.05+0.73%
VNDAVanda Pharmaceutical...-0.10-0.87%
FLXNFlexion Therapeutics...-0.06-0.36%
MYOKMyoKardia Inc+0.73+4.31%
Data as of 3:59pm ET, 07/29/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts

Partner Offers

Search for Jobs